TO FACILITATE BETTER PATIENT OUTCOMES
As we create the world’s most advanced hybrid operating rooms, the passion we have for our patients drives us to bring together groundbreaking technologies to facilitate better outcomes for patients.
IMiND PATIENT REGISTRY
Large multi-center clinical data registries have increasingly shown more powerful and efficient methods by which to study and improve patient outcomes across a variety of diseases and conditions. Numerous studies of various iMRI scanners have shown improvement in extent of resection in surgeries for various types of brain surgeries, which lead to improved patient outcomes. Without a patient registry, it is challenging to assess the advantages of iMRI and to demonstrate improvement
in patient outcomes.
In an effort to address this need, IMRIS partnered with neurosurgeon and principal investigator, Michael Chicoine, M.D., from the Department of Neurosurgery at Washington University School of Medicine in St. Louis, Missouri on a collaborative, multicenter, multi-year iMRI neurosurgery study. Since 2012, the study has collected and stored data from more than 8,000 brain tumor patients in a database called IMiND® REDCap.
Objectives of the study include:
- Assessing the clinical impact of the IMRIS iMRI technology on the extent of lesion resection, survival, and other outcome measures across multiple institutions.
- Establishing best practices to improve the delivery and efficiency of intraoperative imaging procedures.
- Enhancing the understanding of variability, progression, and natural history of the different pathologies treated with intraoperative imaging technology.
- Sharing clinical data for presentations and publications for improving application of these techniques.
- Using the data to facilitate future developments of IMRIS technology.
IMiND offers a convenient and uniform data entry method with secure web-based HIPAA-compliant centralized data storage to help reduce costly data ‘cleaning’ effort during analysis. To date, 11 approved sites and over 8,000 surgical cases have been entered into the IMiND REDCap registry, and approximately half of them are iMRI cases.
As a leading medical technology company, Siemens Healthineers continues to innovate and shape the future of healthcare. Siemens Healthineers has an extensive portfolio of imaging modalities that compliment IMRIS’ expertise in intraoperative imaging for neurosurgery. Siemens Healthineers will continue to remain a crucial partner with IMRIS for years to come.
Hillrom is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by advancing connected care. Around the world, Hillrom innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. Hillrom makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory care devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
ETS-Lindgren is recognized by clients the world over as the leading supplier of energy management solutions for the industrial and commercial markets. Their team of professionals design and manufacture electromagnetic and acoustic energy measurement and shielding systems that make many aspects of modern life possible. With over 75 years of successful innovation, ETS-Lindgren will continue to be a crucial partner of IMRIS for years to come.
VasSol, Inc. is founded on 11 years of multidisciplinary research and clinical work conducted at the University of Illinois at Chicago. Bringing together experts in the fields of circulatory fluid dynamics and computer modeling, we have developed vascular analysis technology that helps answer the fundamental questions that clinicians confront when treating vascular disease. VasSol’s mission is to provide physicians with vital information on the functional consequences of reduced blood flow to guide clinical decision making and help ensure positive outcomes.